Literature DB >> 22110202

Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.

Sandeep Sreevalsan1, Sonia Joseph, Indira Jutooru, Gayathri Chadalapaka, Stephen H Safe.   

Abstract

AIM: We hypothesized that the anticancer activity of cannabinoids was linked to induction of phosphatases.
MATERIALS AND METHODS: The effects of cannabidiol (CBD) and the synthetic cannabinoid WIN-55,212 (WIN) on LNCaP (prostate) and SW480 (colon) cancer cell proliferation were determined by cell counting; apoptosis was determined by cleavage of poly(ADP)ribose polymerase (PARP) and caspase-3 (Western blots); and phosphatase mRNAs were determined by real-time PCR. The role of phosphatases and cannabinoid receptors in mediating CBD- and WIN-induced apoptosis was determined by inhibition and receptor knockdown.
RESULTS: CBD and WIN inhibited LNCaP and SW480 cell growth and induced mRNA expression of several phosphatases, and the phosphatase inhibitor sodium orthovanadate significantly inhibited cannabinoid-induced PARP cleavage in both cell lines, whereas only CBD-induced apoptosis was CB1 and CB2 receptor-dependent.
CONCLUSION: Cannabinoid receptor agonists induce phosphatases and phosphatase-dependent apoptosis in cancer cell lines; however, the role of the CB receptor in mediating this response is ligand-dependent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22110202      PMCID: PMC3280884     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  35 in total

1.  Cannabinoid therapeutics: high hopes for the future.

Authors:  Hensen Bernadette
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851

2.  The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.

Authors:  Arkaitz Carracedo; Mar Lorente; Ainara Egia; Cristina Blázquez; Stephane García; Valentin Giroux; Cedric Malicet; Raquel Villuendas; Meritxell Gironella; Luis González-Feria; Miguel Angel Piris; Juan L Iovanna; Manuel Guzmán; Guillermo Velasco
Journal:  Cancer Cell       Date:  2006-04       Impact factor: 31.743

3.  Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.

Authors:  María M Caffarel; David Sarrió; José Palacios; Manuel Guzmán; Cristina Sánchez
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

4.  Deletion of the dual specific phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP kinase phosphatase-2 (MKP-2) in proliferation and cell survival.

Authors:  Ahmed Lawan; Sameer Al-Harthi; Laurence Cadalbert; Anthony G McCluskey; Muhannad Shweash; Gianluca Grassia; Anne Grant; Marie Boyd; Susan Currie; Robin Plevin
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

5.  Retinoic acid induced repression of AP-1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells.

Authors:  Carmilia Jiménez Ramírez; Juliet M Haberbusch; Dianne Robert Soprano; Kenneth J Soprano
Journal:  J Cell Biochem       Date:  2005-09-01       Impact factor: 4.429

6.  The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.

Authors:  Eva Eljaschewitsch; Anke Witting; Christian Mawrin; Thomas Lee; Peter M Schmidt; Susanne Wolf; Heide Hoertnagl; Cedric S Raine; Regine Schneider-Stock; Robert Nitsch; Oliver Ullrich
Journal:  Neuron       Date:  2006-01-05       Impact factor: 17.173

7.  Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

Authors:  Angelo Vaccani; Paola Massi; Arianna Colombo; Tiziana Rubino; Daniela Parolaro
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 8.  Cannabinoids and cancer: causation, remediation, and palliation.

Authors:  Wayne Hall; MacDonald Christie; David Currow
Journal:  Lancet Oncol       Date:  2005-01       Impact factor: 41.316

9.  Cannabinoid receptor as a novel target for the treatment of prostate cancer.

Authors:  Sami Sarfaraz; Farrukh Afaq; Vaqar M Adhami; Hasan Mukhtar
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

Review 10.  Cannabinoids: potential anticancer agents.

Authors:  Manuel Guzmán
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  23 in total

Review 1.  Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Authors:  Javier Fernández-Ruiz; Onintza Sagredo; M Ruth Pazos; Concepción García; Roger Pertwee; Raphael Mechoulam; José Martínez-Orgado
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 2.  Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review.

Authors:  Camren G Heider; Sasha A Itenberg; Jiajia Rao; Hang Ma; Xian Wu
Journal:  Biology (Basel)       Date:  2022-05-26

Review 3.  Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers.

Authors:  Shreyas Gandhi; Gaurav Vasisth; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-04-11       Impact factor: 1.862

4.  O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.

Authors:  Julia Kargl; Johannes Haybaeck; Angela Stančić; Liisa Andersen; Gunther Marsche; Akos Heinemann; Rudolf Schicho
Journal:  J Mol Med (Berl)       Date:  2012-09-11       Impact factor: 4.599

5.  The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.

Authors:  Sandeep Sreevalsan; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2013-09-12       Impact factor: 6.261

Review 6.  Cannabinoids as therapeutic agents in cancer: current status and future implications.

Authors:  Bandana Chakravarti; Janani Ravi; Ramesh K Ganju
Journal:  Oncotarget       Date:  2014-08-15

Review 7.  Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?

Authors:  Vicente Martínez; Amaia Iriondo De-Hond; Francesca Borrelli; Raffaele Capasso; María Dolores Del Castillo; Raquel Abalo
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

8.  Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.

Authors:  Mariateresa Cipriano; Jenny Häggström; Peter Hammarsten; Christopher J Fowler
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

9.  Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models.

Authors:  Nilkumar Patel; Nagavendra Kommineni; Sunil Kumar Surapaneni; Anil Kalvala; Xuegang Yaun; Aragaw Gebeyehu; Peggy Arthur; Leanne C Duke; Sara B York; Arvind Bagde; David G Meckes; Mandip Singh
Journal:  Int J Pharm       Date:  2021-07-27       Impact factor: 6.510

Review 10.  Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.

Authors:  Ken Soderstrom; Eman Soliman; Rukiyah Van Dross
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.